Acelrx Pharmaceuticals Inc. buy tamam
Start price
23.10.18
/
50%
€70.72
Target price
23.04.19
€131.69
Performance (%)
-13.27%
End price
23.04.19
€61.34
Summary
This prediction ended on 23.04.19 with a price of €61.34. The price of Acelrx Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.27%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Acelrx Pharmaceuticals Inc. | -5.269% | -5.269% | -11.024% | -96.168% |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by tamam for this prediction
In the thread Acelrx Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von stratec zu
tamam stimmt am 23.10.2018 der Buy-Einschätzung von stratec mit dem Kursziel 7,3$ zu.
Überschrift: ACRX PDUFA action date November 3, 2018, for sufentanil for the management of moderate-to-severe pain
(Laufzeit überschritten)
Stopped prediction by tamam for Acelrx Pharmaceuticals Inc.
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€65.49
24.04.19
24.04.19
€117.26
04.11.21
04.11.21
-77.63%
05.11.21
05.11.21